a Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute , Boston , MA , USA.
b Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina , Chapel Hill , NC , USA.
Hum Vaccin Immunother. 2019;15(7-8):1708-1714. doi: 10.1080/21645515.2019.1574150. Epub 2019 Feb 26.
. Health insurers are well-positioned to address low HPV vaccination coverage in the US through initiatives such as provider assessment and feedback. However, little is known about the feasibility of using administrative claims data to assess provider performance on vaccine delivery. . We used administrative claims data from a regional health plan to estimate provider performance on the 2013-2015 Healthcare Effectiveness Data and Information Set (HEDIS) measure for HPV vaccine. This measure required that a girl receive three doses of HPV vaccine by age 13. Providers who administered ≥1 dose in a HEDIS-consistent series received credit for meeting the goal. . From January 2008-April 2015, 1,975 (8.5%) of 11-12 year-old girls in our sample received a HEDIS-consistent HPV vaccine series. Our sample of providers consisted of 1,236 who had ≥10 well-visits with different female patients, and 94% of these were pediatricians. A substantial minority of providers (39.4%) did not administer any HEDIS-consistent HPV vaccine doses. Only 5.5% of providers administered HPV vaccine doses that were part of a HEDIS-consistent series to at least one-quarter of their patients. These estimates did not vary by provider sex or age. Doses in a HEDIS-consistent vaccine series were often attributed to multiple providers. . In a regional health plan, only 5.5% of providers in our sample administered doses that were part of a complete, three-dose HPV vaccine series to at least one-quarter of their 11-12 year-old female patients.
. 健康保险公司通过提供评估和反馈等举措，在美国有能力解决 HPV 疫苗接种率低的问题。然而，利用行政索赔数据来评估提供者在疫苗接种方面的表现的可行性知之甚少。. 我们使用来自区域健康计划的行政索赔数据来估计提供者在 2013-2015 年医疗保健效果数据和信息集（HEDIS）HPV 疫苗测量值上的表现。该措施要求女孩在 13 岁之前接受三剂 HPV 疫苗。提供者在 HEDIS 一致的系列中管理≥1 剂量，则获得符合目标的积分。. 从 2008 年 1 月至 2015 年 4 月，我们样本中的 11-12 岁女孩中有 1975 名（8.5%）接受了 HEDIS 一致的 HPV 疫苗系列。我们的提供者样本包括 1236 名与不同女性患者进行了≥10 次就诊的提供者，其中 94%是儿科医生。少数提供者（39.4%）没有管理任何 HEDIS 一致的 HPV 疫苗剂量。只有 5.5%的提供者至少向其四分之一的患者接种了 HEDIS 一致系列的 HPV 疫苗剂量。这些估计值不受提供者性别或年龄的影响。HEDIS 一致疫苗系列中的剂量通常归因于多个提供者。. 在区域健康计划中，我们的样本中只有 5.5%的提供者为其 11-12 岁的女性患者中的至少四分之一患者接种了至少一剂完整的三剂 HPV 疫苗系列。
